FDA grants fast-track status to possible autism drug
Originally published May 17, 2018 by Disability Scoop
(FDA/Flickr)
The Food and Drug Administration (FDA) accelerated the approval process for medication designed to address the core symptoms of autism. A small clinical trial found lowered irritability, hyperactivity and anxiety, along with improvements in communication among patients. The pharmaceutical company is running additional clinical trials.
Read the full story from Disability Scoop here.
This entry was posted in News, Outside CDS and tagged Autism, Food and Drug Administration (FDA), prescription drugs.